Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05687_nanopub.RAX6fDk8W6aZF5lo4162c91gv4nAmDsgDhtuLgDjaCWKI#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05687 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05687 label "BL-1020 [drugbank:DB05687]" assertion.
- drugbank:DB05687 seeAlso DB05687 assertion.
- drugbank:DB05687 description "BL-1020 is a first in class novel compound for the treatment of schizophrenia. It is being developed by BioLineRx (BioLine)." assertion.
- drugbank:DB05687 identifier "drugbank:DB05687" assertion.
- drugbank:DB05687 title "BL-1020" assertion.
- drugbank:DB05687 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05687 drugbank_vocabulary:drugbank-id "DB05687" assertion.
- drugbank:DB05687 bio2rdf_vocabulary:x-identifiers.org DB05687 assertion.
- drugbank:DB05687 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05687" assertion.
- drugbank:DB05687 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05687 bio2rdf_vocabulary:identifier "DB05687" assertion.